Sidney Hayes, University of Saskatchewan

Research

Read how they describe their research on their University of Saskatchewan profile.

Latest papers

Potential Vaccine or Antimicrobial Reagents: Simple Systems for Producing Lambda Display Particles (LDP) and Sheathed Lambda DNA Vaccine Particles (LDNAP).
Viruses · 2025 · first author
Bacterial Virus Lambda Gpd-Fusions to Cathelicidins, α- and β-Defensins, and Disease-Specific Epitopes Evaluated for Antimicrobial Toxicity and Ability to Support Phage Display.
Viruses · 2019 · first author
The Bacteriophage Lambda CII Phenotypes for Complementation, Cellular Toxicity and Replication Inhibition Are Suppressed in cII-oop Constructs Expressing the Small RNA OOP.
Viruses · 2018 · senior author

All 12 publications

Latest funding

Bacteriophage lambda replication and phage display
NSERC · 2012 · Principal investigator
$130,000
Lambda replication, gene regulation, and recombination
NSERC · 2005 · Principal investigator
$192,500
Bacteriophage lambda replication-coupled processes
NSERC · 2003 · Principal investigator
$24,800

All 5 grants and awards

12 publications.

01

Potential Vaccine or Antimicrobial Reagents: Simple Systems for Producing Lambda Display Particles (LDP) and Sheathed Lambda DNA Vaccine Particles (LDNAP).

Hayes S

Viruses2025First author

DOI: 10.3390/v17111406 PMID: 41305429

02

Bacterial Virus Lambda Gpd-Fusions to Cathelicidins, α- and β-Defensins, and Disease-Specific Epitopes Evaluated for Antimicrobial Toxicity and Ability to Support Phage Display.

Hayes S

Viruses2019First author

DOI: 10.3390/v11090869 PMID: 31533281

03

The Bacteriophage Lambda CII Phenotypes for Complementation, Cellular Toxicity and Replication Inhibition Are Suppressed in cII-oop Constructs Expressing the Small RNA OOP.

Rajamanickam K, Hayes S

Viruses2018Senior author

DOI: 10.3390/v10030115 PMID: 29518935

04

Complementation Studies of Bacteriophage λ O Amber Mutants by Allelic Forms of O Expressed from Plasmid, and O-P Interaction Phenotypes.

Hayes S, Rajamanickam K, Hayes C

Antibiotics (Basel, Switzerland)2018First author

DOI: 10.3390/antibiotics7020031 PMID: 29621200

05

Lambda display phage as a mucosal vaccine delivery vehicle for peptide antigens.

González-Cano P, Gamage LNA, Marciniuk K, Hayes C, Napper S, Hayes S, Griebel PJ

Vaccine201731 citations

DOI: 10.1016/j.vaccine.2017.11.010 PMID: 29153779

06

Lambda gpP-DnaB Helicase Sequestration and gpP-RpoB Associated Effects: On Screens for Auxotrophs, Selection for Rif(R), Toxicity, Mutagenicity, Plasmid Curing.

Hayes S, Wang W, Rajamanickam K, Chu A, Banerjee A, Hayes C

Viruses2016First author

DOI: 10.3390/v8060172 PMID: 27338450

07

Phage Lambda P Protein: Trans-Activation, Inhibition Phenotypes and their Suppression

Sidney Hayes, Craig Alexander Erker, Monique A. Horbay, Kristen Marciniuk, Wen Wang, Connie Hayes

Viruses201316 citationsFirst authorOpen Access

DOI: 10.3390/v5020619 PMID: 23389467

08

A CI-independent form of replicative inhibition: turn off of early replication of bacteriophage lambda.

Hayes S, Horbay MA, Hayes C

PloS one2012First author

DOI: 10.1371/journal.pone.0036498 PMID: 22590552

09

Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2).

Hayes S, Gamage LN, Hayes C

Vaccine2010First author

DOI: 10.1016/j.vaccine.2010.07.047 PMID: 20674873

10

Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes.

Gamage LN, Ellis J, Hayes S

Vaccine2009Senior author

DOI: 10.1016/j.vaccine.2009.08.019 PMID: 19712770